Navigation Links
Arpida Presents Preclinical and Clinical Data on Iclaprim at ICAAC
Date:9/19/2007

REINACH and BASEL, Switzerland, September 19 /PRNewswire-FirstCall/ -- Arpida Ltd (SWX: ARPN) presented a large body of preclinical and clinical data on its investigational drug iclaprim at the 47th annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago. ICAAC is a major scientific conference where thousands of scientists and clinicians from all over the world gather to discuss the latest developments in the field of infectious diseases.

Iclaprim is a novel late stage investigational antibiotic which exhibits potent activity against Gram-positive bacteria including those resistant to current therapies, e.g., MRSA, VISA, VRSA etc. In three separate efficacy trials, iclaprim has been compared against either linezolid or vancomycin and has consistently shown high clinical cure rates. Moreover, clinical experience to date shows that iclaprim is well-tolerated in patients and volunteers. New data presented at ICAAC included large surveillance studies on recent clinical isolates, quality control and CLSI parameters for susceptibility testing, Phase I pharmacokinetic studies and results from the first pivotal Phase III clinical trial (ASSIST-1).

L-1142: ASSIST-1 data on microbiological efficacy in complicated Skin and Skin Structure Infections (cSSSI). Iclaprim showed high microbiological eradication rates against major cSSSI pathogens, comparable with linezolid (MRSA eradication rates were 84.7% vs. 85.3%, respectively). Additional clinical data on safety and efficacy will be presented in October at the upcoming IDSA meeting in San Diego.

E-902, E-904, E-910, E-911: Four posters presented data on large susceptibility studies against recent clinical isolates: iclaprim was the most active compound tested in a study against community-acquired and nosocomial Staphylococcus aureus (poster E-904) and it showed good activity against streptococci and enterococci.

E-906: Iclaprim exhibited rapid bactericidal activi
'/>"/>

SOURCE Arpida Ltd
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. NimbleGen presents new tech for comparing microbe DNA
2. Wisconsin Technology Network presents symposium on saving lives by the use of Information Technology
3. Thieme Presents Unique Technology Angle at Gov.s Conference
4. BioRobot MDx standardize your automated protocols in clinical laboratories
5. What patients want: A story of choice, clinical trials & evidence-based medicine
6. ZyStor seeks to raise $15M for clinical trials
7. Prodesse begins clinical trials for flu virus detection
8. ConjuGon raises $3.3 million to fund clinical trials
9. Cancer-fighting agent heads for clinical trials
10. Quintessence cancer treatment chosen for clinical studies
11. Third Wave reports clinical growth, continued loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2008)...ISBANE, Calif., July 24 /- ...hat it will release second quarter 2008,financial ... July 31, 2008,at 4:00 p.m. Eastern time. A live c...Mune at 4:30 p.m. Eastern time that same day., To... (U.S.) or,706-634-0154 (international), conferenc...
(Date:7/24/2008)... Healthcare Technology Veteran to Help Spearhe...alth Monitoring Systems (HMS), (http://www.hmsinc....said today,that Karen S. Dockrell has been appoint...han 17 years of experience in sales, sales,managem...care technology,medical device and pharmaceutical...
(Date:7/24/2008)...DFORD, Mass., July 24 /- Ho...uccessful completion of the tender,offer by its di...for all,outstanding shares of Third Wave Technolog...r share in cash., The subsequent offering period ...Wednesday, July 23, 2008. The initial tender offer...
(Date:7/24/2008)...sue Dissection System Represents Important Advance... Technologies -, PALO ALTO, Calif., July 24 /PRNe...ompany that has developed a new tissue dissection ...nounced that the U.S. Food and,Drug Administration...t its,PEAK(R) Surgery System for use in general su...
Breaking Biology Technology:InterMune to Release Second Quarter 2008 Financial Results and Provide Business Update on July 31 2Health Monitoring Systems Appoints Karen S. Dockrell As VP, Sales 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 2Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 3Hologic Completes Cash Tender Offer for Third Wave Technologies, Inc. 4PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 2PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 3PEAK Surgical Receives 510(k) Clearance to Market PEAK(R) Surgery System for Use in General Surgery 4
... I recently participated in a roundtable discussio...ts were managers responsible for talent management... firms. The subject of discussion was agile resour...kforce more flexible. The goal of agile resourcing...have the right people, with the right skills, in t...
... Apple provides cluster computers to biology prof...SON A team of University of Wisconsin-Madison sta...uster for Bioinformatics awards . , ,Professor Mi...unduz Keles, Christina Kendziorski and Bret Larget... biological data. , ,Some of the fields they work ...
... MADISON Back in his math teacher days, Al Jacobs...lking about lily pads. Imagine a colony of lily pa...y: How long would it take for an area of two squar...are feet? , ,Only 17 days, thanks to the power of ... 32 and so on, until on the 17th day, 131,072 squa...
... What one thing, if done extremely well, is a powe...ogy commercialization organizations? And what, if ...e answer is delegation. How well you delegate will...ble to commercialize your technology. In this arti...ximize your technology commercialization marketing...
Other Biology Technology:Stuck in Talent Gridlock 2Stuck in Talent Gridlock 3Doubling the lily pads: Controlling the explosion in health care costs 2Doubling the lily pads: Controlling the explosion in health care costs 3Fire up your marketing by delegating 2
(Date:7/25/2008)...born with hydrocephalus, or "water on the brain" m...from the brain to reduce harmful pressure. , Wh...fection in children is very high for a variety of ...another surgery to replace the shunt, bringing wit...ological complications and an increased risk of de...
(Date:7/24/2008)...led by Massachusetts General Hospital (MGH) invest...mic research and medicine a robust method for gen...ar DNA sequences for inactivation or repair. In ...hers describe an efficient, publicly available met...ZFNs), which can be used to induce specific genomi...
(Date:7/24/2008)...by researchers from Columbia University,s Mailman ...challenging issues in infant health and preventing...s. In these settings, HIV-infected mothers had be...ants, they should exclusively breast-feed, followe...h. But according to the study conducted in Lusaka,...
(Date:7/24/2008)... researchers have found a molecular link between c...sm. The discovery reveals new possibilities for th... diseases. , Paolo Sassone-Corsi, Distinguished ...agues have identified that an essential protein ca...thms, works in balance with another protein called...
Breaking Biology News(10 mins):Antimicrobial sutures reduce infections in brain shunt surgery, study finds 2Consortium develops new method enabling routine targeted gene modification 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 2Early cessation of breastfeeding by HIV+ women in poor countries and child survival 3Circadian rhythm-metabolism link discovered 2New efficiency record for solar cells 5414 1New efficiency record for solar cells 5414 2Food 4 Less Expands Discounted Generic Drug Program 19403 1Food 4 Less Expands Discounted Generic Drug Program 19403 2Food 4 Less Expands Discounted Generic Drug Program 19403 3STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 1STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 2STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 3STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 4STEN Corp Reports 2008 Second Quarter Revenue of 244 3 Million and Improved Results From Operations 19400 5Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 19397 1Consumer Watchdog Warns HMO Regulator Not to Side With Insurers Over Illegal Coverage Cancellations 19397 2
...o speed development of new medical products throug...ug Administration (FDA) today issued a final guida...harmacogenomics allows health care providers to id...response and predict the best possible treatment o...sts are helping to identify cancers that have a go...
...rly detection of other tumors one day may be as si...cording to recent studies by UCLA researchers. , ...d here at the 96th Annual Meeting of the American ...ts reported that genetic "biomarkers" isolated in ...bout nine out of 10 cases. , A recent study by thi...
...sha National Park in northern Namibia, and ecologi...on for elephants. "It,s so fantastic here," she sa...bras, ostriches--it,s the Garden of Eden." , A re... of Medicine, O,Connell-Rodwell has come to one of... the mysterious and complex world of elephant comm...
...y,s Pratt School of Engineering have created a new...e. Inserted inside the esophagus, the probe create...s for current ultrasound technology to image a sin...derable potential not only for evaluating the cond...erapeutic treatment devices, the researchers said....
Other Biology News:FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 2FDA Works To Speed The Advent Of New, More Effective Personalized Medicines 3Biomarkers isolated from saliva successfully predict oral and breast cancer 2Scientists journey to southern Africa to unravel the secret world of elephant communication 2Scientists journey to southern Africa to unravel the secret world of elephant communication 3Scientists journey to southern Africa to unravel the secret world of elephant communication 4Scientists journey to southern Africa to unravel the secret world of elephant communication 5Scientists journey to southern Africa to unravel the secret world of elephant communication 6Scientists journey to southern Africa to unravel the secret world of elephant communication 7Scientists journey to southern Africa to unravel the secret world of elephant communication 8Scientists journey to southern Africa to unravel the secret world of elephant communication 9Scientists journey to southern Africa to unravel the secret world of elephant communication 10Scientists journey to southern Africa to unravel the secret world of elephant communication 11Scientists journey to southern Africa to unravel the secret world of elephant communication 12Duke engineers develop new 3-D cardiac imaging probe 2
UltraPure DNase/RNase-Free Distilled Water is designed for use in all molecular biology applications. It is 0.1-m membrane-filtered and tested for DNase and RNase activity.
Immunogen: Synthetic peptide (aa sequence is considered to be commercially sensitive) Storage: -20 C, Avoid Freeze/Thaw Cycles
Immunogen: Human Respiratory Syncytial Virus (RSV) and Bovine Respiratory Syncytial Virus (BRSV) Fusion protein Storage: -20 C, Avoid Freeze/Thaw Cycles
IHC detection kit for PCNA in cells and tissues
Biology Products: